SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01099 SINOPHARM

Pre-opening 05-11 09:19:19

18.570

+0.140

+0.76%

High18.570	Low18.570	Vol0.00
Open18.570	D1 Closing18.430	Amplitude0.00%
Mkt Cap57.96B	Tradable Cap24.92B	Total Shares3.12B
T/O0.00	T/O Rate0.00%	Tradable Shares1.34B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"SINOPHARM","latestPrice":18.57,"timestamp":1778461806004,"preClose":18.43,"halted":0,"volume":0,"delay":0,"changeRate":0.007596310363537741,"floatShares":1341810740,"shares":3121000000,"eps":2.6386286850468896,"marketStatus":"Pre-opening","change":0.14,"latestTime":"05-11 09:19:19","open":18.57,"high":18.57,"low":18.57,"amount":0,"amplitude":0,"askPrice":18.57,"askSize":18400,"bidPrice":18.57,"bidSize":7600,"shortable":3,"etf":0,"ttmEps":2.6139119933774837,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778463000000},"marketStatusCode":1,"adr":0,"listingDate":1253635200000,"exchange":"SEHK","adjPreClose":18.43,"dividendRate":0.04276,"openAndCloseTimeList":[[1778463000000,1778472000000],[1778475600000,1778486400000]],"volumeRatio":0,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK","impliedVol":0.2853,"impliedVolPercentile":0.6194},"requestUrl":"/m/hq/s/01099","defaultTab":"news","newsList":[{"id":"2633435663","title":"Sinopharm Group  Stock Sheds 1.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2633435663","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633435663?lang=en_us&edition=fundamental","pubTime":"2026-05-08 16:33","pubTimestamp":1778229180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. shed 1.6% to 18.43 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 26393.71.The stock's fall snapped a two-day winning streak.Sinopharm Group Co. Ltd. closed 18% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 0.2%.Trading volume totaled 6.2 million shares, compared to the 50-day average of 5.7 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK0096","BK0183","LU0640798160.USD","BK0012","BK4175","BK0239","BK0188","LU1115378108.SGD","BK0187","BK0196","BK0028","BK1515","02196","600196","BK1191","SHTDY","BK0175","BK1197","BK1593","BK0060","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632939644","title":"Sinopharm Group  Stock Advances 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2632939644","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632939644?lang=en_us&edition=fundamental","pubTime":"2026-05-04 16:33","pubTimestamp":1777883580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. rallied 1.4% to 18.73 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 26095.88.Sinopharm Group Co. Ltd. closed 16% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.1%.Trading volume totaled 4.9 million shares, compared to the 50-day average of 5.6 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1500","SHTDY","BK1515","LU1115378108.SGD","BK1197","01099","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631993665","title":"Sinopharm Accord Q1 net profit falls 12.36% to RMB 287.46 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631993665","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631993665?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:59","pubTimestamp":1777456768,"startTime":"0","endTime":"0","summary":"Sinopharm subsidiary Sinopharm Accord posted Q1 2026 revenue of RMB 17.82 billion, down 2.57% year on year.Net profit attributable to shareholders fell to RMB 287.46 million from RMB 328 million.Operating cash flow was RMB -2.94 billion versus RMB -1.82 billion a year earlier.Distribution segment revenue was RMB 13.36 billion, down 1.72%.Retail unit Guoda Drugstore revenue was RMB 4.74 billion, down 4.89%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL96ylqg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK0175","BK0010","BK0196","BK1515","BK0082","BK1500","BK0188","000028","LU0640798160.USD","BK0250","01099","BK0028","LU1115378108.SGD","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631603325","title":"Sinopharm Group  Stock Rallies 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2631603325","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631603325?lang=en_us&edition=fundamental","pubTime":"2026-04-29 16:33","pubTimestamp":1777451580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. rose 1.9% to 18.78 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 26111.84.The stock's rise snapped a six-day losing streak.Sinopharm Group Co. Ltd. closed 16% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.9%.Trading volume totaled 6.7 million shares, compared to the 50-day average of 5.8 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHTDY","BK1197","BK1500","BK1515","BK4175","01099","LU0640798160.USD","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630668893","title":"Sinopharm Group  Stock Falls 3.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2630668893","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630668893?lang=en_us&edition=fundamental","pubTime":"2026-04-27 16:31","pubTimestamp":1777278660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slipped 3.8% to 18.49 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25925.65.This was the stock's fifth consecutive day of losses.Sinopharm Group Co. Ltd. closed 17% short of its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 2.1%.Trading volume totaled 14.2 million shares, compared to the 50-day average of 5.6 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1515","BK1500","BK1197","SHTDY","LU1115378108.SGD","01099","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148447055","title":"Stock Track | SINOPHARM Plummets 5.05% Intraday on Weak Q1 2026 Results Showing Revenue and Profit Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1148447055","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148447055?lang=en_us&edition=fundamental","pubTime":"2026-04-27 14:48","pubTimestamp":1777272527,"startTime":"0","endTime":"0","summary":"SINOPHARM's stock plummeted 5.05% during intraday trading on Monday, following the release of the company's first-quarter 2026 financial results.The decline was triggered by disappointing quarterly...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630359230","title":"BUZZ-Sinopharm Group touches 6-month low as quarterly profit slips","url":"https://stock-news.laohu8.com/highlight/detail?id=2630359230","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630359230?lang=en_us&edition=fundamental","pubTime":"2026-04-27 12:11","pubTimestamp":1777263086,"startTime":"0","endTime":"0","summary":"BUZZ-Sinopharm Group touches 6-month low as quarterly profit slips** Shares of Sinopharm Group 1099.HK slip 2.8% to HK$18.68, their lowest level since October 21** Stock set for the biggest one-day pct fall since April 13, and on course for the fifth straight session of decline** China-based pharmaceutical and healthcare products and medical devices distributor said its net profit for the three months ended in March slipped 3% y/y to 1.41 billion yuan  ** YTD, stock down 3.9%, while Hang Seng Biotech Index .HSBIO up 3.8%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL1N41A02W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","BK1197","LU1115378108.SGD","LU0640798160.USD","BK1500","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630335803","title":"Sinopharm Group Records Drop in Q1 2026 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2630335803","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630335803?lang=en_us&edition=fundamental","pubTime":"2026-04-27 09:54","pubTimestamp":1777254889,"startTime":"0","endTime":"0","summary":"Sinopharm Group  booked 1.41 billion yuan in attributable profit for the first quarter of 2026, falling from 1.46 billion yuan in the year-ago period, according to a Hong Kong bourse filing Monday.Earnings per share were 0.45 yuan, compared with 0.47 yuan in the prior year.Total operating revenue fell to 140.77 billion yuan from 141.66 billion yuan, figures showed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01099","LU1115378108.SGD","BK1197","BK1500","BK1515","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630302183","title":"BRIEF-Sinopharm Group Posts Qtrly Total Operating Revenue RMB 140.77 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2630302183","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630302183?lang=en_us&edition=fundamental","pubTime":"2026-04-27 09:22","pubTimestamp":1777252936,"startTime":"0","endTime":"0","summary":"BRIEF-Sinopharm Group Posts Qtrly Total Operating Revenue RMB 140.77 BillionApril 27 (Reuters) - Sinopharm Group Co Ltd 1099.HK:SINOPHARM GROUP: QTRLY TOTAL OPERATING REVENUE RMB 140.77 BILLIONSINOPHA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nFWN4171F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU1115378108.SGD","BK1515","LU0640798160.USD","BK1197","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149487056","title":"SINOPHARM Reports Q1 Net Profit of 1.41 Billion Yuan, Down 2.95% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1149487056","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149487056?lang=en_us&edition=fundamental","pubTime":"2026-04-27 08:04","pubTimestamp":1777248258,"startTime":"0","endTime":"0","summary":"SINOPHARM (01099) announced its quarterly results for the three months ended March 31, 2026. The company recorded total operating revenue of 140.77 billion yuan, a decrease of 0.63% compared to the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK1197","BK1515","LU0640798160.USD","LU1115378108.SGD","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171465168","title":"Sinopharm Q1-2026: Revenue Slips 0.6%, Attributable Profit Down 3.0% amid Higher Working-Capital Needs","url":"https://stock-news.laohu8.com/highlight/detail?id=1171465168","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171465168?lang=en_us&edition=fundamental","pubTime":"2026-04-27 07:43","pubTimestamp":1777246990,"startTime":"0","endTime":"0","summary":"Sinopharm Group Co. Ltd. released unaudited first-quarter 2026 results prepared under PRC GAAP. Revenue and Profitability   • Operating revenue edged down 0.63% year on year (YoY) to RMB140.77...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630334039","title":"Sinopharm Group: Qtrly Total Operating Revenue RMB 140.77 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2630334039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630334039?lang=en_us&edition=fundamental","pubTime":"2026-04-27 07:39","pubTimestamp":1777246784,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nFWN4171F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01099","BK1197","LU1115378108.SGD","LU0640798160.USD","BK1500","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630054334","title":"Sinopharm Q1 net profit falls 3.06% to RMB 2.19 billion; revenue slips to RMB 140.77 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2630054334","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630054334?lang=en_us&edition=fundamental","pubTime":"2026-04-27 07:38","pubTimestamp":1777246688,"startTime":"0","endTime":"0","summary":"Sinopharm posted net profit of RMB 2.19 billion for three months ended March 31, 2026, while profit attributable to shareholders came in at RMB 1.41 billion.Net cash used in operating activities narrowed to RMB 32.17 billion, while cash and cash equivalents fell to RMB 24.08 billion at quarter-end.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nNDL9fZyS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1197","BK1515","LU1115378108.SGD","BK1500","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100738539","title":"国药控股2025年经营概况：营收5751.68亿元，零售板块同比上扬","url":"https://stock-news.laohu8.com/highlight/detail?id=1100738539","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100738539?lang=en_us&edition=fundamental","pubTime":"2026-04-24 16:56","pubTimestamp":1777020966,"startTime":"0","endTime":"0","summary":"国药控股（SINOPHARM，股票代码：01099）公布截至2025年12月31日的年度报告。公司持续聚焦医药分销、医疗器械分销及零售连锁等核心业务，并在报告期内实现稳定的经营与盈利能力。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"国药控股2025年经营概况：营收5751.68亿元，零售板块同比上扬","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148114882","title":"Sinopharm 2025 Sustainability Report: Deeper ESG Integration, Lower Emissions and Wider Healthcare Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=1148114882","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148114882?lang=en_us&edition=fundamental","pubTime":"2026-04-24 16:48","pubTimestamp":1777020495,"startTime":"0","endTime":"0","summary":"Sinopharm’s latest Sustainability Report details a year-long push to embed environmental, social and governance (ESG) principles throughout its pharmaceutical distribution, medical-device and retail...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629106816","title":"Sinopharm publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629106816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629106816?lang=en_us&edition=fundamental","pubTime":"2026-04-24 16:32","pubTimestamp":1777019531,"startTime":"0","endTime":"0","summary":"Sinopharm released annual report for 12 months ended Dec. 31, 2025, showing profit growth despite revenue decline amid industry pricing pressure.Management cited recovery from Q3 following a first-half downturn, supported by tighter cost control and improved operating cash flow.Retail pharmacy delivered turnaround momentum, with Guoda Drugstore cutting net loss to RMB 217 million from RMB 1.1 billion.Pharmaceutical distribution held operating margin broadly stable as group pushed market-share gains in core regions.Medical device distribution shifted toward higher value-added service projects, expanding SPD and centralized distribution coverage across 30 provinces.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL8D1mcL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","01099","LU0640798160.USD","BK1500","LU1115378108.SGD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629379038","title":"Sinopharm Arm's Operating Profit Slips 20% in Q1","url":"https://stock-news.laohu8.com/highlight/detail?id=2629379038","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629379038?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:20","pubTimestamp":1776950438,"startTime":"0","endTime":"0","summary":"Sinopharm  unit China National Medical Device recorded an operating profit of 220.2 million yuan in the first quarter of 2026, down 20% from 276.7 million yuan a year prior, according to a Thursday Hong Kong bourse filing.Revenue jumped 1.2% to 17 billion yuan from 16.8 billion yuan in the prior-year period.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0640798160.USD","LU1115378108.SGD","BK1515","BK1500","BK1197","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629839475","title":"Sinopharm Group (SEHK:1099) Q1 Net Margin Of 1.6% Tests Thin Profit Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2629839475","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629839475?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:12","pubTimestamp":1776942740,"startTime":"0","endTime":"0","summary":"Sinopharm Group (SEHK:1099) opened 2026 with Q1 revenue of about CNY 17.8b and basic EPS of CNY 0.52, setting the tone against a trailing twelve month profile that shows revenue of roughly CNY 574.7b and EPS of CNY 2.28. Over recent quarters investors have seen quarterly revenue move from about CNY 141.7b in Q1 2025 to CNY 145.4b in Q3 2025 and CNY 143.7b in Q4 2025, with basic EPS ranging from CNY 0.47 to CNY 3.29 across that period as the business cycled through different earnings levels...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-sehk1099-q1-net-margin-of-16-tests-thin-prof","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-sehk1099-q1-net-margin-of-16-tests-thin-prof","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1500","LU1115378108.SGD","BK1515","LU0640798160.USD","BK1197","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193178557","title":"SINOPHARM’s Subsidiary CNMDC Posts 1.23% Revenue Growth but 20.41% Profit Slide in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1193178557","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193178557?lang=en_us&edition=fundamental","pubTime":"2026-04-23 17:09","pubTimestamp":1776935376,"startTime":"0","endTime":"0","summary":"Hong Kong, 23 Apr 2026 – Sinopharm Group Co. Ltd. (SINOPHARM) announced key unaudited figures for its medical-device subsidiary China National Medical Device Co., Ltd. (CNMDC) covering the three...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190034826","title":"SINOPHARM Unit Reports 20.41% Drop in Q1 Operating Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1190034826","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190034826?lang=en_us&edition=fundamental","pubTime":"2026-04-23 17:04","pubTimestamp":1776935066,"startTime":"0","endTime":"0","summary":"SINOPHARM (01099) has released financial results for its subsidiary, China National Medical Device Co., Ltd., for the three-month period ended March 31, 2026. The subsidiary reported operating...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","BK1197","LU1115378108.SGD","LU0640798160.USD","BK1515","BK1500"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":-0.1428},{"period":"3month","weight":-0.1315},{"period":"6month","weight":-0.0767},{"period":"1year","weight":0.0474},{"period":"ytd","weight":-0.052}],"compareEarnings":[{"period":"1week","weight":0.0239},{"period":"1month","weight":0.0193},{"period":"3month","weight":-0.0063},{"period":"6month","weight":0.0058},{"period":"1year","weight":0.1588},{"period":"ytd","weight":0.0298}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sinopharm Group Co Ltd is a China-based company principally engaged in the wholesale and retail of pharmaceutical and healthcare products and medical devices. The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.004643},{"month":2,"riseRate":0.588235,"avgChangeRate":0.029413},{"month":3,"riseRate":0.470588,"avgChangeRate":0.007007},{"month":4,"riseRate":0.411765,"avgChangeRate":0.016485},{"month":5,"riseRate":0.588235,"avgChangeRate":-0.004408},{"month":6,"riseRate":0.4375,"avgChangeRate":-0.005852},{"month":7,"riseRate":0.5,"avgChangeRate":-0.015111},{"month":8,"riseRate":0.4375,"avgChangeRate":0.012101},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.011177},{"month":10,"riseRate":0.647059,"avgChangeRate":0.042295},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.007287},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.004122}],"exchange":"SEHK","name":"SINOPHARM","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SINOPHARM(01099) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SINOPHARM,01099,SINOPHARM股票,SINOPHARM股票老虎,SINOPHARM股票老虎国际,SINOPHARM行情,SINOPHARM股票行情,SINOPHARM股价,SINOPHARM股市,SINOPHARM股票价格,SINOPHARM股票交易,SINOPHARM股票购买,SINOPHARM股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SINOPHARM(01099) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}